NCT01055184
- Conditions
- 2009 H1N1 Influenza Virus, Infections, Influenza, Human, +5 more
- Locations
-
- University of Rochester Medical Center, Vaccine Research Unit Rochester, New York, United States
Clinical trial condition
Influenza, Human
Explore clinical trials studying Influenza, Human. Study availability and eligibility vary by location and protocol.
1,849 public trials
84 recruiting studies
Influenza, Human trial results
NCT01938170
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- University of North Carolina Chapel Hill, North Carolina, United States
NCT00551031
- Conditions
- Infections, Influenza, Influenza, Human, +6 more
- Locations
-
- Alabaster, Alabama, United States
- Mobile, Alabama, United States
- Chandler, Arizona, United States
- Mesa, Arizona, United States
Completed
A Study of High-Dose Trivalent Inactivated Influenza Vaccine in Adults 50 to 64 Years of Age
NCT01258595
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- Idaho Falls, Idaho, United States
- Columbia, Maryland, United States
- Ellicott City, Maryland, United States
- Missoula, Montana, United States
NCT00743275
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- Norfolk, Virginia, United States
NCT02006524
- Conditions
- Arrhythmias, Cardiac, Atrial Fibrillation, Cardiovascular Diseases, +10 more
- Locations
-
- General Practices Groningen, Provincie Groningen, Netherlands
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- Center For Vaccinology Ghent, Belgium
NCT02107807
- Conditions
- Animal Diseases, Bird Diseases, Flu, Avian, +11 more
- Locations
-
- 102, Novartis Investigational Site Darlinghurst, New South Wales, Australia
- 103, Novartis Investigational Site Darlinghurst, New South Wales, Australia
- 101, Novartis Investigational Site Merewether, New South Wales, Australia
- 303, Novartis Investiagtional Site Würzburg, Bavaria, Germany
NCT01646138
- Conditions
- Infections, Influenza, Influenza, Human, +5 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Completed
Infliximab IBD Influenza Vaccine Study
NCT01666535
- Conditions
- Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, +10 more
- Locations
-
- University of Calgary Calgary, Alberta, Canada